WCN26-8307 THE THERAPEUTIC POTENTIAL OF CARVACROL IN CHRONIC KIDNEY DISEASE AND THE GUT–KIDNEY AXIS

Read full text Summarise with VIRAT
Authors: Rafaela Lopes Xavier, Christiany Moreira Almeida, Ana Caroline Peixoto Lima, Isabella Maravalha Gomes, Jorge Luís Alarcón Alcântara, Larissa Gabriele Paixão Fontes, M. O. Maia, Lucas Kirschner Camargo Neves, Marvin Florêncio Sarubby do Nascimento, RANNYER VICTOR SILVA AGUIAR, Rebeca Jordana Santos Freitas Félix, Sophia Cabus Arcoverde
+3 more Víctor Gabriel Tsuchida de Medeiros, Vitória Piffero Junges Oliveira, Carla Aparecida Souza Hoffmann
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Chronic Kidney Disease (CKD) represents a major global public health problem, affecting between 6% and 10% of the world's population. Conventional pharmacological treatment, although aiding in blood pressure, glycemia, and metabolic disorder control, frequently results in gut microbiota imbalances in renal patients. These imbalances are associated with gastrointestinal disturbances arising from continuous medication use, making non-pharmacological nutritional strategies, such as phytotherapeutics, promising alternatives.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Dialysis and Renal Disease Management Gut microbiota and health

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105405–105405
Publication date
25 March 2026
Language
EN